JESSICA KIM: Open Payments
NPI 1245941046 · WOODBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 36 payments from 12 companies in 2025. Trend: 2023 $19 · 2024 $379 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $154 |
| ABBVIE INC. | 6 | $123 |
| Ardelyx, Inc. | 6 | $117 |
| Phathom Pharmaceuticals, Inc. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Novo Nordisk Inc | 2 | $41 |
| PFIZER INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: XIFAXAN, IBSRELA, VOQUEZNA, VIBERZI, DUPIXENT, Wegovy, ENTYVIO, LINZESS.
Industry payments across NY — which companies pay providers there.
